Cupps Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-41,611
| Closed | -$1.35M | – | 178 |
|
2016
Q2 | $1.35M | Sell |
41,611
-83,242
| -67% | -$2.7M | 0.35% | 105 |
|
2016
Q1 | $3.49M | Buy |
124,853
+104,238
| +506% | +$2.91M | 0.67% | 61 |
|
2015
Q4 | $734K | Buy |
+20,615
| New | +$734K | 0.1% | 122 |
|
2015
Q2 | – | Sell |
-153,717
| Closed | -$5.01M | – | 188 |
|
2015
Q1 | $5.01M | Sell |
153,717
-118,633
| -44% | -$3.87M | 0.45% | 81 |
|
2014
Q4 | $8.65M | Sell |
272,350
-48,471
| -15% | -$1.54M | 0.77% | 45 |
|
2014
Q3 | $7.94M | Sell |
320,821
-99,590
| -24% | -$2.47M | 0.74% | 49 |
|
2014
Q2 | $9.5M | Sell |
420,411
-3,621
| -0.9% | -$81.8K | 0.77% | 49 |
|
2014
Q1 | $10.3M | Sell |
424,032
-419,819
| -50% | -$10.2M | 0.79% | 44 |
|
2013
Q4 | $21.1M | Sell |
843,851
-76,166
| -8% | -$1.9M | 1.43% | 17 |
|
2013
Q3 | $25.3M | Sell |
920,017
-24,913
| -3% | -$684K | 1.64% | 15 |
|
2013
Q2 | $17.2M | Buy |
+944,930
| New | +$17.2M | 1.37% | 23 |
|